Medico Remedies Ltd Stock Price Today (NSE: MEDICO)
Fundamental Score
Medico Remedies Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Medico Remedies Ltd share price today is ₹45.99, up +0.00% on NSE/BSE as of 20 February 2026. Medico Remedies Ltd (MEDICO) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹431.60 (Cr). The 52-week high for MEDICO share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 38.03x, MEDICO is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 17.57% and a debt-to-equity ratio of 0.19.
Medico Remedies Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Medico Remedies Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Medico Remedies Share Price
The pharmaceutical industry, known for its resilience even during economic downturns due to consistent healthcare demand, presents a complex landscape for stock valuation. This analysis examines the current financial standing of Medico Remedies share price (₹47.810001) based on publicly available data, as part of an 80-parameter fundamental audit verified by Sweta Mishra. The analysis is observational and does not constitute investment advice.
Medico Remedies Ltd currently trades at a Price-to-Earnings (PE) ratio of 38.03. This indicates the market's expectation for future earnings growth. When compared to sector peers such as
Mankind Pharma Ltd, a key consideration is the quality of management and its ability to execute strategic initiatives. While Mankind Pharma enjoys a generally favorable perception in terms of corporate governance and operational efficiency, evaluating Medico Remedies' management requires deeper qualitative analysis beyond just the PE ratio. This includes assessing their track record, transparency, and investor communication.A significant strength for Medico Remedies is its Return on Capital Employed (ROCE) of 21.31%. ROCE measures how efficiently a company generates profits from its capital. A high ROCE, such as the one displayed by Medico Remedies, suggests a stronger competitive advantage or "moat." This is because it indicates the company is generating attractive returns on its investments, potentially creating barriers to entry for competitors. Maintaining and improving this ROCE is crucial for the long-term sustainability and growth of the company. Its ROCE performance is to be observed against companies like Smruthi Organics Ltd and Balaxi Pharmaceuticals Ltd.
Further comprehensive analysis requires detailed examination of balance sheets, income statements, cash flow statements, and overall industry trends. Factors such as debt levels, revenue growth, and regulatory approvals also play a vital role in assessing the long-term financial health of Medico Remedies Ltd.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Medico Remedies Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MEDICO across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (17.57%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (21.31%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Robust Profit Growth (65.81%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (33.77%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Excellent EPS Growth (43.93% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (43.99% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.19)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (12.71x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (61.38%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Negative Free Cash Flow (₹-22.06 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.31%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Medico Remedies Ltd Financial Statements
Comprehensive financial data for Medico Remedies Ltd including income statement, balance sheet and cash flow
About MEDICO (Medico Remedies Ltd)
Medico Remedies Ltd (MEDICO) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current market capitalisation of ₹431.60 (Cr). Medico Remedies Ltd has delivered a Return on Equity (ROE) of 17.57% and a ROCE of 21.31%. The debt-to-equity ratio stands at 0.19, reflecting the company's capital structure. Investors tracking MEDICO share price can monitor key metrics including P/E ratio, promoter holding of 61.38%, and quarterly earnings growth.
Company Details
Key Leadership
Latest News
MEDICO Share Price: Frequently Asked Questions
What is the current share price of Medico Remedies Ltd (MEDICO)?
As of 20 Feb 2026, 06:17 am IST, Medico Remedies Ltd share price is ₹45.99. The MEDICO stock has a market capitalisation of ₹431.60 (Cr) on NSE/BSE.
Is MEDICO share price Overvalued or Undervalued?
MEDICO share price is currently trading at a P/E ratio of 38.03x, compared to the industry average of 31.77x. Based on this relative valuation, the Medico Remedies Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of MEDICO share price?
The 52-week high of MEDICO share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Medico Remedies Ltd share price?
Key factors influencing MEDICO share price include quarterly earnings growth (Sales Growth: 33.77%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Medico Remedies Ltd a good stock for long-term investment?
Medico Remedies Ltd shows a 5-year Profit Growth of 43.99% and an ROE of 17.57%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.19 before investing in MEDICO shares.
How does Medico Remedies Ltd compare with its industry peers?
Medico Remedies Ltd competes with major peers in the Pharmaceuticals. Investors should compare MEDICO share price P/E of 38.03x and ROE of 17.57% against the industry averages to determine competitive standing.
What is the P/E ratio of MEDICO and what does it mean?
MEDICO share price has a P/E ratio of 38.03x compared to the industry average of 31.77x. Investors pay ₹38 for every ₹1 of annual earnings.
How is MEDICO performing according to Bull Run's analysis?
MEDICO has a Bull Run fundamental score of 64.8/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does MEDICO belong to?
MEDICO operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Medico Remedies Ltd share price.
What is Return on Equity (ROE) and why is it important for MEDICO?
MEDICO has an ROE of 17.57%, which indicates excellent management efficiency. ROE measures how efficiently Medico Remedies Ltd generates profits from shareholders capital.
How is MEDICO debt-to-equity ratio and what does it indicate?
MEDICO has a debt-to-equity ratio of 0.19, which indicates conservative financing with low financial risk.
What is MEDICO dividend yield and is it a good dividend stock?
MEDICO offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Medico Remedies Ltd shares.
How has MEDICO share price grown over the past 5 years?
MEDICO has achieved 5-year growth rates of: Sales Growth 11.23%, Profit Growth 43.99%, and EPS Growth 43.93%.
What is the promoter holding in MEDICO and why does it matter?
Promoters hold 61.38% of MEDICO shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Medico Remedies Ltd.
What is MEDICO market capitalisation category?
MEDICO has a market capitalisation of ₹432 crores, placing it in the Small-cap category.
How volatile is MEDICO stock?
MEDICO has a beta of N/A. A beta > 1 suggests the Medico Remedies Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is MEDICO operating profit margin trend?
MEDICO has a 5-year average Operating Profit Margin (OPM) of 7.38%, indicating the company's operational efficiency.
How is MEDICO quarterly performance?
Recent quarterly performance shows Medico Remedies Ltd YoY Sales Growth of 33.77% and YoY Profit Growth of 65.81%.
What is the institutional holding pattern in MEDICO?
MEDICO has FII holding of 0.30% and DII holding of 0.01%. Significant institutional holding often suggests professional confidence in the Medico Remedies Ltd stock.